Miyuki Abe

Beppu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy.

Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 28, 2026

ASO Visual Abstract: Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung Cancer.

ASO Visual Abstract: Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung Cancer.

Journal: Annals of surgical oncology

Published: June 20, 2026

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Journal: Annals of surgical oncology

Published: March 25, 2026

Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study.

Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 18, 2025

Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study.

Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study.

Journal: Annals of surgical oncology

Published: December 17, 2025

Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung Cancer.

Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung Cancer.

Journal: Annals of surgical oncology

Published: December 03, 2025

Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective cohort study.

Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective cohort study.

Journal: Journal of thoracic disease

Published: September 26, 2025

A Case of Mediastinitis Due to Fulminant Group A Streptococcal Infection.

A Case of Mediastinitis Due to Fulminant Group A Streptococcal Infection.

Journal: Surgical case reports

Published: September 25, 2025

Pathological Complete Response in Locally Advanced ALK Fusion Gene-Positive Lung Adenocarcinoma following Salvage Surgery: A Case Report and Literature Review.

Pathological Complete Response in Locally Advanced ALK Fusion Gene-Positive Lung Adenocarcinoma following Salvage Surgery: A Case Report and Literature Review.

Journal: Surgical case reports

Published: April 23, 2025

Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus).

Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus).

Journal: The Annals of thoracic surgery

Published: April 18, 2025

Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III NSCLC.

Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III NSCLC.

Journal: JTO clinical and research reports

Published: April 09, 2025

Philadelphia Chromosome as a Clinically Favorable Prognostic Factor of B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Transplant-Ineligible Elderly Patients in the Era of Molecular-Targeted Therapy.

Philadelphia Chromosome as a Clinically Favorable Prognostic Factor of B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Transplant-Ineligible Elderly Patients in the Era of Molecular-Targeted Therapy.

Journal: Cureus

Published: November 19, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026